Global Glioma Treatment Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Page: 155
Published Date: 13 Jan 2025
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Glioma Treatment market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Chemotherapy is usually used in combination with radiation therapy to treat gliomas. The chemotherapy drug used most often to treat gliomas is temozolomide (Temodar), which is taken as a pill. Side effects of chemotherapy depend on the type and dose of drugs you receive.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Glioma Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Glioma Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Glioma Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Glioma Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Glioma Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Glioma Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Glioma Treatment market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sun Pharmaceutical, Amgen, Teva Pharmaceutical, Bristol-Myers Squibb, Pfizer, Merck, Eli Lilly, F. Hoffmann-La Roche Ltd, AbbVie, Genentech, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Glioma Treatment market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
ChemOthersapy
Drugs
Market segment by Application
Hospitals
Cancer Research Organizations
Diagnostic Centers
Others
Major players covered
Sun Pharmaceutical
Amgen
Teva Pharmaceutical
Bristol-Myers Squibb
Pfizer
Merck
Eli Lilly
F. Hoffmann-La Roche Ltd
AbbVie
Genentech
BioMimetix
Cipla
Sigma-Aldrich
Panacea Biotec
Zydus Cadila
Takeda Pharmaceuticals
Boston Biomedical
Ziopharm Oncology
Celldex Therapeutics
BERG
Oncorus
Agenus
Deciphera Pharmaceuticals
Karyopharm Therapeutics
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Glioma Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Glioma Treatment, with price, sales quantity, revenue, and global market share of Glioma Treatment from 2020 to 2025.
Chapter 3, the Glioma Treatment competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Glioma Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Glioma Treatment market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Glioma Treatment.
Chapter 14 and 15, to describe Glioma Treatment sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Glioma Treatment Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 ChemOthersapy
1.3.3 Drugs
1.4 Market Analysis by Application
1.4.1 Overview: Global Glioma Treatment Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals
1.4.3 Cancer Research Organizations
1.4.4 Diagnostic Centers
1.4.5 Others
1.5 Global Glioma Treatment Market Size & Forecast
1.5.1 Global Glioma Treatment Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Glioma Treatment Sales Quantity (2020-2031)
1.5.3 Global Glioma Treatment Average Price (2020-2031)
2.1 Sun Pharmaceutical
2.1.1 Sun Pharmaceutical Details
2.1.2 Sun Pharmaceutical Major Business
2.1.3 Sun Pharmaceutical Glioma Treatment Product and Services
2.1.4 Sun Pharmaceutical Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 Sun Pharmaceutical Recent Developments/Updates
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Glioma Treatment Product and Services
2.2.4 Amgen Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Amgen Recent Developments/Updates
2.3 Teva Pharmaceutical
2.3.1 Teva Pharmaceutical Details
2.3.2 Teva Pharmaceutical Major Business
2.3.3 Teva Pharmaceutical Glioma Treatment Product and Services
2.3.4 Teva Pharmaceutical Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Teva Pharmaceutical Recent Developments/Updates
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Glioma Treatment Product and Services
2.4.4 Bristol-Myers Squibb Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Bristol-Myers Squibb Recent Developments/Updates
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Glioma Treatment Product and Services
2.5.4 Pfizer Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Pfizer Recent Developments/Updates
2.6 Merck
2.6.1 Merck Details
2.6.2 Merck Major Business
2.6.3 Merck Glioma Treatment Product and Services
2.6.4 Merck Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Merck Recent Developments/Updates
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business
2.7.3 Eli Lilly Glioma Treatment Product and Services
2.7.4 Eli Lilly Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Eli Lilly Recent Developments/Updates
2.8 F. Hoffmann-La Roche Ltd
2.8.1 F. Hoffmann-La Roche Ltd Details
2.8.2 F. Hoffmann-La Roche Ltd Major Business
2.8.3 F. Hoffmann-La Roche Ltd Glioma Treatment Product and Services
2.8.4 F. Hoffmann-La Roche Ltd Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
2.9 AbbVie
2.9.1 AbbVie Details
2.9.2 AbbVie Major Business
2.9.3 AbbVie Glioma Treatment Product and Services
2.9.4 AbbVie Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 AbbVie Recent Developments/Updates
2.10 Genentech
2.10.1 Genentech Details
2.10.2 Genentech Major Business
2.10.3 Genentech Glioma Treatment Product and Services
2.10.4 Genentech Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Genentech Recent Developments/Updates
2.11 BioMimetix
2.11.1 BioMimetix Details
2.11.2 BioMimetix Major Business
2.11.3 BioMimetix Glioma Treatment Product and Services
2.11.4 BioMimetix Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 BioMimetix Recent Developments/Updates
2.12 Cipla
2.12.1 Cipla Details
2.12.2 Cipla Major Business
2.12.3 Cipla Glioma Treatment Product and Services
2.12.4 Cipla Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Cipla Recent Developments/Updates
2.13 Sigma-Aldrich
2.13.1 Sigma-Aldrich Details
2.13.2 Sigma-Aldrich Major Business
2.13.3 Sigma-Aldrich Glioma Treatment Product and Services
2.13.4 Sigma-Aldrich Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Sigma-Aldrich Recent Developments/Updates
2.14 Panacea Biotec
2.14.1 Panacea Biotec Details
2.14.2 Panacea Biotec Major Business
2.14.3 Panacea Biotec Glioma Treatment Product and Services
2.14.4 Panacea Biotec Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Panacea Biotec Recent Developments/Updates
2.15 Zydus Cadila
2.15.1 Zydus Cadila Details
2.15.2 Zydus Cadila Major Business
2.15.3 Zydus Cadila Glioma Treatment Product and Services
2.15.4 Zydus Cadila Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 Zydus Cadila Recent Developments/Updates
2.16 Takeda Pharmaceuticals
2.16.1 Takeda Pharmaceuticals Details
2.16.2 Takeda Pharmaceuticals Major Business
2.16.3 Takeda Pharmaceuticals Glioma Treatment Product and Services
2.16.4 Takeda Pharmaceuticals Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Takeda Pharmaceuticals Recent Developments/Updates
2.17 Boston Biomedical
2.17.1 Boston Biomedical Details
2.17.2 Boston Biomedical Major Business
2.17.3 Boston Biomedical Glioma Treatment Product and Services
2.17.4 Boston Biomedical Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Boston Biomedical Recent Developments/Updates
2.18 Ziopharm Oncology
2.18.1 Ziopharm Oncology Details
2.18.2 Ziopharm Oncology Major Business
2.18.3 Ziopharm Oncology Glioma Treatment Product and Services
2.18.4 Ziopharm Oncology Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Ziopharm Oncology Recent Developments/Updates
2.19 Celldex Therapeutics
2.19.1 Celldex Therapeutics Details
2.19.2 Celldex Therapeutics Major Business
2.19.3 Celldex Therapeutics Glioma Treatment Product and Services
2.19.4 Celldex Therapeutics Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Celldex Therapeutics Recent Developments/Updates
2.20 BERG
2.20.1 BERG Details
2.20.2 BERG Major Business
2.20.3 BERG Glioma Treatment Product and Services
2.20.4 BERG Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 BERG Recent Developments/Updates
2.21 Oncorus
2.21.1 Oncorus Details
2.21.2 Oncorus Major Business
2.21.3 Oncorus Glioma Treatment Product and Services
2.21.4 Oncorus Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Oncorus Recent Developments/Updates
2.22 Agenus
2.22.1 Agenus Details
2.22.2 Agenus Major Business
2.22.3 Agenus Glioma Treatment Product and Services
2.22.4 Agenus Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 Agenus Recent Developments/Updates
2.23 Deciphera Pharmaceuticals
2.23.1 Deciphera Pharmaceuticals Details
2.23.2 Deciphera Pharmaceuticals Major Business
2.23.3 Deciphera Pharmaceuticals Glioma Treatment Product and Services
2.23.4 Deciphera Pharmaceuticals Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.23.5 Deciphera Pharmaceuticals Recent Developments/Updates
2.24 Karyopharm Therapeutics
2.24.1 Karyopharm Therapeutics Details
2.24.2 Karyopharm Therapeutics Major Business
2.24.3 Karyopharm Therapeutics Glioma Treatment Product and Services
2.24.4 Karyopharm Therapeutics Glioma Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.24.5 Karyopharm Therapeutics Recent Developments/Updates
3.1 Global Glioma Treatment Sales Quantity by Manufacturer (2020-2025)
3.2 Global Glioma Treatment Revenue by Manufacturer (2020-2025)
3.3 Global Glioma Treatment Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Glioma Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Glioma Treatment Manufacturer Market Share in 2024
3.4.3 Top 6 Glioma Treatment Manufacturer Market Share in 2024
3.5 Glioma Treatment Market: Overall Company Footprint Analysis
3.5.1 Glioma Treatment Market: Region Footprint
3.5.2 Glioma Treatment Market: Company Product Type Footprint
3.5.3 Glioma Treatment Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Glioma Treatment Market Size by Region
4.1.1 Global Glioma Treatment Sales Quantity by Region (2020-2031)
4.1.2 Global Glioma Treatment Consumption Value by Region (2020-2031)
4.1.3 Global Glioma Treatment Average Price by Region (2020-2031)
4.2 North America Glioma Treatment Consumption Value (2020-2031)
4.3 Europe Glioma Treatment Consumption Value (2020-2031)
4.4 Asia-Pacific Glioma Treatment Consumption Value (2020-2031)
4.5 South America Glioma Treatment Consumption Value (2020-2031)
4.6 Middle East & Africa Glioma Treatment Consumption Value (2020-2031)
5.1 Global Glioma Treatment Sales Quantity by Type (2020-2031)
5.2 Global Glioma Treatment Consumption Value by Type (2020-2031)
5.3 Global Glioma Treatment Average Price by Type (2020-2031)
6.1 Global Glioma Treatment Sales Quantity by Application (2020-2031)
6.2 Global Glioma Treatment Consumption Value by Application (2020-2031)
6.3 Global Glioma Treatment Average Price by Application (2020-2031)
7.1 North America Glioma Treatment Sales Quantity by Type (2020-2031)
7.2 North America Glioma Treatment Sales Quantity by Application (2020-2031)
7.3 North America Glioma Treatment Market Size by Country
7.3.1 North America Glioma Treatment Sales Quantity by Country (2020-2031)
7.3.2 North America Glioma Treatment Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8.1 Europe Glioma Treatment Sales Quantity by Type (2020-2031)
8.2 Europe Glioma Treatment Sales Quantity by Application (2020-2031)
8.3 Europe Glioma Treatment Market Size by Country
8.3.1 Europe Glioma Treatment Sales Quantity by Country (2020-2031)
8.3.2 Europe Glioma Treatment Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9.1 Asia-Pacific Glioma Treatment Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Glioma Treatment Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Glioma Treatment Market Size by Region
9.3.1 Asia-Pacific Glioma Treatment Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Glioma Treatment Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10.1 South America Glioma Treatment Sales Quantity by Type (2020-2031)
10.2 South America Glioma Treatment Sales Quantity by Application (2020-2031)
10.3 South America Glioma Treatment Market Size by Country
10.3.1 South America Glioma Treatment Sales Quantity by Country (2020-2031)
10.3.2 South America Glioma Treatment Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11.1 Middle East & Africa Glioma Treatment Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Glioma Treatment Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Glioma Treatment Market Size by Country
11.3.1 Middle East & Africa Glioma Treatment Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Glioma Treatment Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12.1 Glioma Treatment Market Drivers
12.2 Glioma Treatment Market Restraints
12.3 Glioma Treatment Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Glioma Treatment and Key Manufacturers
13.2 Manufacturing Costs Percentage of Glioma Treatment
13.3 Glioma Treatment Production Process
13.4 Industry Value Chain Analysis
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Glioma Treatment Typical Distributors
14.3 Glioma Treatment Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Glioma Treatment Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Glioma Treatment Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Sun Pharmaceutical Major Business
Table 5. Sun Pharmaceutical Glioma Treatment Product and Services
Table 6. Sun Pharmaceutical Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. Sun Pharmaceutical Recent Developments/Updates
Table 8. Amgen Basic Information, Manufacturing Base and Competitors
Table 9. Amgen Major Business
Table 10. Amgen Glioma Treatment Product and Services
Table 11. Amgen Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Amgen Recent Developments/Updates
Table 13. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 14. Teva Pharmaceutical Major Business
Table 15. Teva Pharmaceutical Glioma Treatment Product and Services
Table 16. Teva Pharmaceutical Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Teva Pharmaceutical Recent Developments/Updates
Table 18. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 19. Bristol-Myers Squibb Major Business
Table 20. Bristol-Myers Squibb Glioma Treatment Product and Services
Table 21. Bristol-Myers Squibb Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Bristol-Myers Squibb Recent Developments/Updates
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer Glioma Treatment Product and Services
Table 26. Pfizer Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Pfizer Recent Developments/Updates
Table 28. Merck Basic Information, Manufacturing Base and Competitors
Table 29. Merck Major Business
Table 30. Merck Glioma Treatment Product and Services
Table 31. Merck Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Merck Recent Developments/Updates
Table 33. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 34. Eli Lilly Major Business
Table 35. Eli Lilly Glioma Treatment Product and Services
Table 36. Eli Lilly Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Eli Lilly Recent Developments/Updates
Table 38. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 39. F. Hoffmann-La Roche Ltd Major Business
Table 40. F. Hoffmann-La Roche Ltd Glioma Treatment Product and Services
Table 41. F. Hoffmann-La Roche Ltd Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 43. AbbVie Basic Information, Manufacturing Base and Competitors
Table 44. AbbVie Major Business
Table 45. AbbVie Glioma Treatment Product and Services
Table 46. AbbVie Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. AbbVie Recent Developments/Updates
Table 48. Genentech Basic Information, Manufacturing Base and Competitors
Table 49. Genentech Major Business
Table 50. Genentech Glioma Treatment Product and Services
Table 51. Genentech Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Genentech Recent Developments/Updates
Table 53. BioMimetix Basic Information, Manufacturing Base and Competitors
Table 54. BioMimetix Major Business
Table 55. BioMimetix Glioma Treatment Product and Services
Table 56. BioMimetix Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. BioMimetix Recent Developments/Updates
Table 58. Cipla Basic Information, Manufacturing Base and Competitors
Table 59. Cipla Major Business
Table 60. Cipla Glioma Treatment Product and Services
Table 61. Cipla Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Cipla Recent Developments/Updates
Table 63. Sigma-Aldrich Basic Information, Manufacturing Base and Competitors
Table 64. Sigma-Aldrich Major Business
Table 65. Sigma-Aldrich Glioma Treatment Product and Services
Table 66. Sigma-Aldrich Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 67. Sigma-Aldrich Recent Developments/Updates
Table 68. Panacea Biotec Basic Information, Manufacturing Base and Competitors
Table 69. Panacea Biotec Major Business
Table 70. Panacea Biotec Glioma Treatment Product and Services
Table 71. Panacea Biotec Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 72. Panacea Biotec Recent Developments/Updates
Table 73. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 74. Zydus Cadila Major Business
Table 75. Zydus Cadila Glioma Treatment Product and Services
Table 76. Zydus Cadila Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 77. Zydus Cadila Recent Developments/Updates
Table 78. Takeda Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 79. Takeda Pharmaceuticals Major Business
Table 80. Takeda Pharmaceuticals Glioma Treatment Product and Services
Table 81. Takeda Pharmaceuticals Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 82. Takeda Pharmaceuticals Recent Developments/Updates
Table 83. Boston Biomedical Basic Information, Manufacturing Base and Competitors
Table 84. Boston Biomedical Major Business
Table 85. Boston Biomedical Glioma Treatment Product and Services
Table 86. Boston Biomedical Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 87. Boston Biomedical Recent Developments/Updates
Table 88. Ziopharm Oncology Basic Information, Manufacturing Base and Competitors
Table 89. Ziopharm Oncology Major Business
Table 90. Ziopharm Oncology Glioma Treatment Product and Services
Table 91. Ziopharm Oncology Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 92. Ziopharm Oncology Recent Developments/Updates
Table 93. Celldex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 94. Celldex Therapeutics Major Business
Table 95. Celldex Therapeutics Glioma Treatment Product and Services
Table 96. Celldex Therapeutics Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 97. Celldex Therapeutics Recent Developments/Updates
Table 98. BERG Basic Information, Manufacturing Base and Competitors
Table 99. BERG Major Business
Table 100. BERG Glioma Treatment Product and Services
Table 101. BERG Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 102. BERG Recent Developments/Updates
Table 103. Oncorus Basic Information, Manufacturing Base and Competitors
Table 104. Oncorus Major Business
Table 105. Oncorus Glioma Treatment Product and Services
Table 106. Oncorus Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 107. Oncorus Recent Developments/Updates
Table 108. Agenus Basic Information, Manufacturing Base and Competitors
Table 109. Agenus Major Business
Table 110. Agenus Glioma Treatment Product and Services
Table 111. Agenus Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 112. Agenus Recent Developments/Updates
Table 113. Deciphera Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 114. Deciphera Pharmaceuticals Major Business
Table 115. Deciphera Pharmaceuticals Glioma Treatment Product and Services
Table 116. Deciphera Pharmaceuticals Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 117. Deciphera Pharmaceuticals Recent Developments/Updates
Table 118. Karyopharm Therapeutics Basic Information, Manufacturing Base and Competitors
Table 119. Karyopharm Therapeutics Major Business
Table 120. Karyopharm Therapeutics Glioma Treatment Product and Services
Table 121. Karyopharm Therapeutics Glioma Treatment Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 122. Karyopharm Therapeutics Recent Developments/Updates
Table 123. Global Glioma Treatment Sales Quantity by Manufacturer (2020-2025) & (K Units)
Table 124. Global Glioma Treatment Revenue by Manufacturer (2020-2025) & (USD Million)
Table 125. Global Glioma Treatment Average Price by Manufacturer (2020-2025) & (US$/Unit)
Table 126. Market Position of Manufacturers in Glioma Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 127. Head Office and Glioma Treatment Production Site of Key Manufacturer
Table 128. Glioma Treatment Market: Company Product Type Footprint
Table 129. Glioma Treatment Market: Company Product Application Footprint
Table 130. Glioma Treatment New Market Entrants and Barriers to Market Entry
Table 131. Glioma Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 132. Global Glioma Treatment Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 133. Global Glioma Treatment Sales Quantity by Region (2020-2025) & (K Units)
Table 134. Global Glioma Treatment Sales Quantity by Region (2026-2031) & (K Units)
Table 135. Global Glioma Treatment Consumption Value by Region (2020-2025) & (USD Million)
Table 136. Global Glioma Treatment Consumption Value by Region (2026-2031) & (USD Million)
Table 137. Global Glioma Treatment Average Price by Region (2020-2025) & (US$/Unit)
Table 138. Global Glioma Treatment Average Price by Region (2026-2031) & (US$/Unit)
Table 139. Global Glioma Treatment Sales Quantity by Type (2020-2025) & (K Units)
Table 140. Global Glioma Treatment Sales Quantity by Type (2026-2031) & (K Units)
Table 141. Global Glioma Treatment Consumption Value by Type (2020-2025) & (USD Million)
Table 142. Global Glioma Treatment Consumption Value by Type (2026-2031) & (USD Million)
Table 143. Global Glioma Treatment Average Price by Type (2020-2025) & (US$/Unit)
Table 144. Global Glioma Treatment Average Price by Type (2026-2031) & (US$/Unit)
Table 145. Global Glioma Treatment Sales Quantity by Application (2020-2025) & (K Units)
Table 146. Global Glioma Treatment Sales Quantity by Application (2026-2031) & (K Units)
Table 147. Global Glioma Treatment Consumption Value by Application (2020-2025) & (USD Million)
Table 148. Global Glioma Treatment Consumption Value by Application (2026-2031) & (USD Million)
Table 149. Global Glioma Treatment Average Price by Application (2020-2025) & (US$/Unit)
Table 150. Global Glioma Treatment Average Price by Application (2026-2031) & (US$/Unit)
Table 151. North America Glioma Treatment Sales Quantity by Type (2020-2025) & (K Units)
Table 152. North America Glioma Treatment Sales Quantity by Type (2026-2031) & (K Units)
Table 153. North America Glioma Treatment Sales Quantity by Application (2020-2025) & (K Units)
Table 154. North America Glioma Treatment Sales Quantity by Application (2026-2031) & (K Units)
Table 155. North America Glioma Treatment Sales Quantity by Country (2020-2025) & (K Units)
Table 156. North America Glioma Treatment Sales Quantity by Country (2026-2031) & (K Units)
Table 157. North America Glioma Treatment Consumption Value by Country (2020-2025) & (USD Million)
Table 158. North America Glioma Treatment Consumption Value by Country (2026-2031) & (USD Million)
Table 159. Europe Glioma Treatment Sales Quantity by Type (2020-2025) & (K Units)
Table 160. Europe Glioma Treatment Sales Quantity by Type (2026-2031) & (K Units)
Table 161. Europe Glioma Treatment Sales Quantity by Application (2020-2025) & (K Units)
Table 162. Europe Glioma Treatment Sales Quantity by Application (2026-2031) & (K Units)
Table 163. Europe Glioma Treatment Sales Quantity by Country (2020-2025) & (K Units)
Table 164. Europe Glioma Treatment Sales Quantity by Country (2026-2031) & (K Units)
Table 165. Europe Glioma Treatment Consumption Value by Country (2020-2025) & (USD Million)
Table 166. Europe Glioma Treatment Consumption Value by Country (2026-2031) & (USD Million)
Table 167. Asia-Pacific Glioma Treatment Sales Quantity by Type (2020-2025) & (K Units)
Table 168. Asia-Pacific Glioma Treatment Sales Quantity by Type (2026-2031) & (K Units)
Table 169. Asia-Pacific Glioma Treatment Sales Quantity by Application (2020-2025) & (K Units)
Table 170. Asia-Pacific Glioma Treatment Sales Quantity by Application (2026-2031) & (K Units)
Table 171. Asia-Pacific Glioma Treatment Sales Quantity by Region (2020-2025) & (K Units)
Table 172. Asia-Pacific Glioma Treatment Sales Quantity by Region (2026-2031) & (K Units)
Table 173. Asia-Pacific Glioma Treatment Consumption Value by Region (2020-2025) & (USD Million)
Table 174. Asia-Pacific Glioma Treatment Consumption Value by Region (2026-2031) & (USD Million)
Table 175. South America Glioma Treatment Sales Quantity by Type (2020-2025) & (K Units)
Table 176. South America Glioma Treatment Sales Quantity by Type (2026-2031) & (K Units)
Table 177. South America Glioma Treatment Sales Quantity by Application (2020-2025) & (K Units)
Table 178. South America Glioma Treatment Sales Quantity by Application (2026-2031) & (K Units)
Table 179. South America Glioma Treatment Sales Quantity by Country (2020-2025) & (K Units)
Table 180. South America Glioma Treatment Sales Quantity by Country (2026-2031) & (K Units)
Table 181. South America Glioma Treatment Consumption Value by Country (2020-2025) & (USD Million)
Table 182. South America Glioma Treatment Consumption Value by Country (2026-2031) & (USD Million)
Table 183. Middle East & Africa Glioma Treatment Sales Quantity by Type (2020-2025) & (K Units)
Table 184. Middle East & Africa Glioma Treatment Sales Quantity by Type (2026-2031) & (K Units)
Table 185. Middle East & Africa Glioma Treatment Sales Quantity by Application (2020-2025) & (K Units)
Table 186. Middle East & Africa Glioma Treatment Sales Quantity by Application (2026-2031) & (K Units)
Table 187. Middle East & Africa Glioma Treatment Sales Quantity by Country (2020-2025) & (K Units)
Table 188. Middle East & Africa Glioma Treatment Sales Quantity by Country (2026-2031) & (K Units)
Table 189. Middle East & Africa Glioma Treatment Consumption Value by Country (2020-2025) & (USD Million)
Table 190. Middle East & Africa Glioma Treatment Consumption Value by Country (2026-2031) & (USD Million)
Table 191. Glioma Treatment Raw Material
Table 192. Key Manufacturers of Glioma Treatment Raw Materials
Table 193. Glioma Treatment Typical Distributors
Table 194. Glioma Treatment Typical Customers
List of Figures
Figure 1. Glioma Treatment Picture
Figure 2. Global Glioma Treatment Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Glioma Treatment Revenue Market Share by Type in 2024
Figure 4. ChemOthersapy Examples
Figure 5. Drugs Examples
Figure 6. Global Glioma Treatment Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 7. Global Glioma Treatment Revenue Market Share by Application in 2024
Figure 8. Hospitals Examples
Figure 9. Cancer Research Organizations Examples
Figure 10. Diagnostic Centers Examples
Figure 11. Others Examples
Figure 12. Global Glioma Treatment Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 13. Global Glioma Treatment Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 14. Global Glioma Treatment Sales Quantity (2020-2031) & (K Units)
Figure 15. Global Glioma Treatment Price (2020-2031) & (US$/Unit)
Figure 16. Global Glioma Treatment Sales Quantity Market Share by Manufacturer in 2024
Figure 17. Global Glioma Treatment Revenue Market Share by Manufacturer in 2024
Figure 18. Producer Shipments of Glioma Treatment by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 19. Top 3 Glioma Treatment Manufacturer (Revenue) Market Share in 2024
Figure 20. Top 6 Glioma Treatment Manufacturer (Revenue) Market Share in 2024
Figure 21. Global Glioma Treatment Sales Quantity Market Share by Region (2020-2031)
Figure 22. Global Glioma Treatment Consumption Value Market Share by Region (2020-2031)
Figure 23. North America Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 24. Europe Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 25. Asia-Pacific Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 26. South America Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 27. Middle East & Africa Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 28. Global Glioma Treatment Sales Quantity Market Share by Type (2020-2031)
Figure 29. Global Glioma Treatment Consumption Value Market Share by Type (2020-2031)
Figure 30. Global Glioma Treatment Average Price by Type (2020-2031) & (US$/Unit)
Figure 31. Global Glioma Treatment Sales Quantity Market Share by Application (2020-2031)
Figure 32. Global Glioma Treatment Revenue Market Share by Application (2020-2031)
Figure 33. Global Glioma Treatment Average Price by Application (2020-2031) & (US$/Unit)
Figure 34. North America Glioma Treatment Sales Quantity Market Share by Type (2020-2031)
Figure 35. North America Glioma Treatment Sales Quantity Market Share by Application (2020-2031)
Figure 36. North America Glioma Treatment Sales Quantity Market Share by Country (2020-2031)
Figure 37. North America Glioma Treatment Consumption Value Market Share by Country (2020-2031)
Figure 38. United States Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 39. Canada Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 40. Mexico Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 41. Europe Glioma Treatment Sales Quantity Market Share by Type (2020-2031)
Figure 42. Europe Glioma Treatment Sales Quantity Market Share by Application (2020-2031)
Figure 43. Europe Glioma Treatment Sales Quantity Market Share by Country (2020-2031)
Figure 44. Europe Glioma Treatment Consumption Value Market Share by Country (2020-2031)
Figure 45. Germany Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 46. France Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 47. United Kingdom Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 48. Russia Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 49. Italy Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 50. Asia-Pacific Glioma Treatment Sales Quantity Market Share by Type (2020-2031)
Figure 51. Asia-Pacific Glioma Treatment Sales Quantity Market Share by Application (2020-2031)
Figure 52. Asia-Pacific Glioma Treatment Sales Quantity Market Share by Region (2020-2031)
Figure 53. Asia-Pacific Glioma Treatment Consumption Value Market Share by Region (2020-2031)
Figure 54. China Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 55. Japan Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 56. South Korea Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 57. India Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 58. Southeast Asia Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 59. Australia Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 60. South America Glioma Treatment Sales Quantity Market Share by Type (2020-2031)
Figure 61. South America Glioma Treatment Sales Quantity Market Share by Application (2020-2031)
Figure 62. South America Glioma Treatment Sales Quantity Market Share by Country (2020-2031)
Figure 63. South America Glioma Treatment Consumption Value Market Share by Country (2020-2031)
Figure 64. Brazil Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 65. Argentina Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 66. Middle East & Africa Glioma Treatment Sales Quantity Market Share by Type (2020-2031)
Figure 67. Middle East & Africa Glioma Treatment Sales Quantity Market Share by Application (2020-2031)
Figure 68. Middle East & Africa Glioma Treatment Sales Quantity Market Share by Country (2020-2031)
Figure 69. Middle East & Africa Glioma Treatment Consumption Value Market Share by Country (2020-2031)
Figure 70. Turkey Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 71. Egypt Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 72. Saudi Arabia Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 73. South Africa Glioma Treatment Consumption Value (2020-2031) & (USD Million)
Figure 74. Glioma Treatment Market Drivers
Figure 75. Glioma Treatment Market Restraints
Figure 76. Glioma Treatment Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Glioma Treatment in 2024
Figure 79. Manufacturing Process Analysis of Glioma Treatment
Figure 80. Glioma Treatment Industrial Chain
Figure 81. Sales Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Sun Pharmaceutical Amgen Teva Pharmaceutical Bristol-Myers Squibb Pfizer Merck Eli Lilly F. Hoffmann-La Roche Ltd AbbVie Genentech BioMimetix Cipla Sigma-Aldrich Panacea Biotec Zydus Cadila Takeda Pharmaceuticals Boston Biomedical Ziopharm Oncology Celldex Therapeutics BERG Oncorus Agenus Deciphera Pharmaceuticals Karyopharm Therapeutics
Related Reports
10 Feb 2023
Medical Care
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
